1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394-424. DOI: 10.3322/caac.21492. Epub 2018 Sep 12. Erratum in: CA Cancer J Clin. 2020 Jul;70(4):313. PMID: 30207593.
2. McCormack V, Newton R. Research priorities for social inequalities in cancer in sub-Saharan Africa. 150 cours Albert Thomas, 69372 Lyon Cedex 08, France© International Agency for Research on Cancer, 2019 Distributed by WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland. 2019:319.
3. Federal Ministry of Health; Ethiopia: National Cancer Control Plan 2016–2020 October 2015: Addis Ababa Ethiopia, [internet], [cited,2020, Dec 15]; available from https://www.iccp-portal.org/
4. Addis Ababa City Cancer Registry E. Addis Ababa City Cancer Registry Cancer Incidence Report. African Cancer Registry Network, 2019 [internet], [cited ,2020 Dec,20]; Available fromhttps://afcrn.org/membership/members/100-Addisababa www.iccpportal.org/sites/default/files/plans/NCCP%20Ethiopia%20Final%20261015.pdf
5. Parkin DM, Hämmerl L, Ferlay J, Kantelhardt EJ (2020) Cancer in Africa 2018: The role of infections. International Journal of Cancer 146(8):2089-2103.
6. Persec Z, Persec J, Sović T, Romic Z, Bosnar Herak M, Hrgovic Z. Metastatic prostate cancer in an asymptomatic patient with an initial prostate-specific antigen (PSA) serum concentration of 21,380 ng/ml. Onkologie. 2010;33(3):110-2. DOI: 10.1159/000277743. Epub 2010 Feb 22. PMID: 20215802.
7. Bashir MN. Epidemiology of Prostate Cancer. Asian Pac J Cancer Prev. 2015;16(13):5137-41. DOI: 10.7314/apjcp.2015.16.13.5137. PMID: 26225642.
8. Banerjee S, Kaviani A. Worldwide prostate cancer epidemiology: Differences between regions, races, and awareness programs. International Journal of Clinical and Experimental Medical Sciences. 2016;2.
9. Rawla P. Epidemiology of Prostate Cancer. World J Oncol. 2019 Apr;10(2):63-89. DOI: 10.14740/wjon1191. Epub 2019 Apr 20. PMID: 31068988; PMCID: PMC6497009.
10. Wolf AM, Wender RC, Etzioni RB, Thompson IM, D'Amico AV, Volk RJ, Brooks DD, Dash C, Guessous I, Andrews K, DeSantis C, Smith RA; American Cancer Society Prostate Cancer Advisory Committee. American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin. 2010 Mar-Apr;60(2):70-98. DOI: 10.3322/caac.20066. Epub 2010 Mar 3. PMID: 20200110.
11. Pernar CH, Ebot EM, Wilson KM, Mucci LA. The Epidemiology of Prostate Cancer. Cold Spring Harb Perspect Med. 2018 Dec 3;8(12): a030361. DOI: 10.1101/cshperspect. a030361. PMID: 29311132; PMCID: PMC6280714.
12. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30. doi: 10.3322/caac.21332. Epub 2016 Jan 7. PMID: 26742998.
13. Smith RA, Andrews KS, Brooks D, Fedewa SA, Manassaram-Baptiste D, Saslow D, Wender RC. Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2019 May;69(3):184-210. DOI: 10.3322/caac.21557. Epub 2019 Mar 15. PMID: 30875085.
14. Chua ME, Lapitan MC, Morales ML Jr, Roque AB, Domingo JK; Philippine Urological Residents Association (PURA). 2013 Annual National Digital Rectal Exam Day: impact on prostate health awareness and disease detection. Prostate Int. 2014 Mar;2(1):31-6. DOI: 10.12954/PI.13039. Epub 2014 Mar 30. PMID: 24693532; PMCID: PMC3970987.
15. Brawley OW. Trends in prostate cancer in the United States. J Natl Cancer Inst Monogr. 2012 Dec;2012(45):152-6. DOI: 10.1093/jncimonographs/lgs035. PMID: 23271766; PMCID: PMC3540881.
16. Mahal BA, Berman RA, Taplin ME, Huang FW. Prostate Cancer-Specific Mortality Across Gleason Scores in Black vs Nonblack Men. JAMA. 2018 Dec 18;320(23):2479-2481. DOI: 10.1001/jama.2018.11716. PMID: 30561471.
17. Sungur M, Caliskan S. Awareness of prostate cancer diagnosis and management among Turkish males: a cross-sectional study from Çorum. Aging Male. 2020 Sep;23(3):202-205. DOI: 10.1080/13685538.2019.1577377. Epub 2019 Apr 22. PMID: 31007118.
18. Agbugui JO, Obarisiagbon EO, Nwajei CO, Osaigbovo EO, Okolo JC, Akinyele AO. Awareness and knowledge of prostate cancer among men in Benin City, Nigeria. Journal of Medicine and Biomedical Research. 2013;12(2):42-7.
19. Oranusi CK, Mbieri UT, Oranusi IO, Nwofor AM. Prostate cancer awareness and screening among male public servants in Anambra State, Nigeria. African Journal of Urology. 2012 Jun 1;18(2):72-4.
20. Mofolo N, Betshu O, Kenna O, Koroma S, Lebeko T, Claassen FM, Joubert G. Knowledge of prostate cancer among males attending a urology clinic, a South African study. Springerplus. 2015 Feb 10; 4:67. DOI: 10.1186/s40064-015-0824-y. PMID: 25713760; PMCID: PMC4329121.
21. Nakandi H, Kirabo M, Semugabo C, Kittengo A, Kitayimbwa P, Kalungi S, Maena J. Knowledge, attitudes and practices of Ugandan men regarding prostate cancer. Afr J Urol. 2013 Dec;19(4):165-170. DOI: 10.1016/j.afju.2013.08.001. PMID: 25221428; PMCID: PMC4162513.
22. Awosan KJ, Yunusa EU, Agwu NP, Taofiq S. Knowledge of prostate cancer and screening practices among men in Sokoto, Nigeria. Asian Journal of Medical Sciences. 2018 Oct 29;9(6):51-6.
23. Ojewola RW, Oridota ES, Balogun OS, Ogundare EO, Alabi TO, Banjo OO, Laoye A, Adetunmbi B, Adebayo BO, Oluyombo R. Knowledge, attitudes and screening practices regarding prostatic diseases among men older than 40 years: a population-based study in Southwest Nigeria. Pan Afr Med J. 2017 Jun 30; 27:151. DOI: 10.11604/pamj.2017.27.151.10605. PMID: 28904679; PMCID: PMC5567951.
24. Benurugo G, Munyambaraga E, Chironda G, Bisanukuri E. Awareness on prostate cancer and screening practices among men attending outpatient at a referral hospital in Kigali, Rwanda: A quantitative study. International Journal of Africa Nursing Sciences. 2020 Jan 1; 13:100241.
25. Solomon S, Mulugeta W. Diagnosis and Risk Factors of Advantage Cancers in Ethiopia. J Cancer Prev. 2019 Sep;24(3):163-172. DOI: 10.15430/JCP.2019.24.3.163. Epub 2019 Sep 30. PMID: 31624722; PMCID: PMC6786804.
26. Shephard RJ. Physical Activity and Prostate Cancer: An Updated Review. Sports Med. 2017 Jun;47(6):1055-1073. DOI: 10.1007/s40279-016-0648-0. PMID: 27844337.
27. Beksisa J, Getinet T, Tanie S, Diribi J, Hassen HY. Survival and prognostic determinants of prostate cancer patients in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: A retrospective cohort study. PLoS One. 2020 Mar 5;15(3): e0229854. DOI: 10.1371/journal.pone.0229854. PMID: 32134996; PMCID: PMC7058322.
28. Background of Tikur Anbessa Hospital College of Health Sciences [Internet]. [cited 2020 Dec.20]. Available from: http://www.aau.edu.et/chs/tikur-anbessa-specializedhospital /background-of-tikur-anbessa-hospital/
29. Tikur Anbessa Specialized Hospital Urology Unit manager office. 2020.
30. Cochran WG, William G Sampling Techniques. New York: John Wiley & Sons. Inc; 1977.
31. Morlando M, Pelullo CP, Di Giuseppe G. Prostate cancer screening: Knowledge, attitudes, and practices in a sample of men in Italy. A survey. PLoS One. 2017 Oct 12;12(10): e0186332. DOI: 10.1371/journal.pone.0186332. PMID: 29023514; PMCID: PMC5638517.
32. Connor K, Hudson B, Power E. Awareness of the Signs, Symptoms, and Risk Factors of Cancer and the Barriers to Seeking Help in the UK: Comparison of Survey Data Collected Online and Face-to-Face. JMIR Cancer. 2020 Jan 17;6(1): e14539. DOI: 10.2196/14539. PMID: 31951219; PMCID: PMC6996748.
33. Agbugui JO, Obarisiagbon EO, Nwajei CO, Osaigbovo EO, Okolo JC, Akinyele AO. Awareness and knowledge of prostate cancer among men in Benin City, Nigeria. Journal of Medicine and Biomedical Research. 2013;12(2):42-7.
34. Yeboah ed. Prevalence of benign prostatic hyperplasia and prostate cancer in Africans and Africans in the diaspora. J west afr Coll Surg. 2016 oct-dec;6(4):1-30. Pmid: 29181363; pmcid: pmc5667727
35. Hvidberg L, Pedersen AF, Wulff CN, Vedsted P. Cancer awareness and socio-economic position: results from a population-based study in Denmark. BMC Cancer. 2014 Aug 9; 14:581. DOI: 10.1186/1471-2407-14-581. PMID: 25108301; PMCID: PMC4138385.
36. Kangmennaang J, Mkandawire P, Luginaah I. What Prevents Men Aged 40-64 Years from Prostate Cancer Screening in Namibia? J Cancer Epidemiol. 2016; 2016:7962502. DOI: 10.1155/2016/7962502. Epub 2016 Jan 10. PMID: 26880917; PMCID: PMC4736914.
37. Arafa MA, Rabah DM, Wahdan IH. Awareness of general public towards cancer prostate and screening practice in Arabic communities: a comparative multi-center study. Asian Pac J Cancer Prev. 2012;13(9):4321-6. DOI: 10.7314/apjcp.2012.13.9.4321. PMID: 23167336.
38. Xu J, Sun J, Zheng SL. Prostate cancer risk-associated genetic markers and their potential clinical utility. Asian J Andros. 2013 May;15(3):314-22. DOI: 10.1038/aja.2013.42. Epub 2013 Apr 8. PMID: 23564047; PMCID: PMC3739659.
39. Ogunsanya ME, Brown CM, Odedina FT, Barner JC, Adedipe TB, Corbell B. Knowledge of Prostate Cancer and Screening Among Young Multiethnic Black Men. Am J Men's Health. 2017 Jul;11(4):1008-1018. DOI: 10.1177/1557988316689497. Epub 2017 Jan 31. PMID: 28139152; PMCID: PMC5675316.
40. Mabuza LH, Omole OB, Govender I, Ndimande JV, Schoeman HS. Inpatients' awareness of admission reasons and management plans of their clinical conditions at a tertiary hospital in South Africa. BMC Health Serv Res. 2015 Mar 6; 15:89. DOI: 10.1186/s12913-015-0754-y. PMID: 25889177; PMCID: PMC4359431.
41. Active Citizen Network (2006). European Charter of Patients’ Rights. https://ec.europa.eu/health/ph_overview/co_operation/mobility/docs/health_services_co108_en.pdf.[Cited 2020 December 13]